Form 4: Bioventus Inc. Director Ladone Receives 26,493 Restricted Stock Units

Director Mary Kay Ladone acquired 26,493 restricted stock units (RSUs) of Bioventus Inc. on June 11, 2024, which will vest on the earlier of the next annual meeting or the first anniversary of the grant date.

Summary

• On June 11, 2024, Mary Kay Ladone, a director of Bioventus Inc. (BVS), was granted 26,493 restricted stock units (RSUs).
• Each RSU represents the right to receive one share of Class A common stock.
• The RSUs will vest on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, contingent upon continued service on the Issuer's Board of Directors.
• Following this transaction, Ladone beneficially owns 26,493 RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the director's continued service and contribution to the company.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The vesting of the RSUs is contingent upon the director's continued service on the board, aligning her interests with the long-term performance of the company.

Industry Context

Grants of restricted stock units are a common form of executive compensation, particularly for directors, to align their interests with those of shareholders and incentivize long-term value creation.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.

Key Dates